Lilly and Durham-based Precision BioSciences disclose a deal involving Precision’s gene editing technology on Friday morning that could be worth as much as $555 million. Duchenne muscular dystrophy is the initial target.
Read More
Eli Lilly and Company said Monday it has started the first human trial of an antibody therapy designed to treat COVID-19. Here’s a look at what’s happening.
Read More
Pharmaceutical giant Eli Lilly has selected a site within the old GlaxoSmithKline campus – now known as Parmer RTP – for a massive manufacturing complex.
Read More
Global pharmaceutical giant Eli Lilly & Co. (NYSE: LLY) plans to build a production facility in RTP, creating 462 jobs over the next five years,
Read More
